Skip to main content

Advertisement

ADVERTISEMENT

Exclusives

News
01/22/2024
Noridian will host a lymphedema compression treatment webinar on Feb 13, 2024. The webinar will cover the lymphedema compression treatment benefit category, policy information, coding and billing, and documentation requirements.
Noridian will host a lymphedema compression treatment webinar on Feb 13, 2024. The webinar will cover the lymphedema compression treatment benefit category, policy information, coding and billing, and documentation requirements.
Noridian will host a lymphedema...
01/22/2024
Wound Care
News
01/22/2024
The Bipartisan Policy Cente reported on the Future of Remote Patient Monitoring. The report looks broadly at ways to improve the use of remote monitoring services, ensure equitable access to these services across populations and enhance data...
The Bipartisan Policy Cente reported on the Future of Remote Patient Monitoring. The report looks broadly at ways to improve the use of remote monitoring services, ensure equitable access to these services across populations and enhance data...
The Bipartisan Policy Cente...
01/22/2024
Wound Care
News
01/22/2024
A 660-patient study will evaluate NPWT (Prevena and PICO) versus standard dressings in preventing complete sternotomy scar dehiscence in cardiac surgery. The estimated study completion date is July 15, 2025. clinicaltrials.gov
A 660-patient study will evaluate NPWT (Prevena and PICO) versus standard dressings in preventing complete sternotomy scar dehiscence in cardiac surgery. The estimated study completion date is July 15, 2025. clinicaltrials.gov
A 660-patient study will...
01/22/2024
Wound Care
News
01/22/2024
A study on the usage of skin substitutes in a VA system& found that only 15.6% of patients for whom the matrices were ordered had supporting lab tests. Of the ordered matrices, 34.3% were not applied. And, the use of matrices resulted in...
A study on the usage of skin substitutes in a VA system& found that only 15.6% of patients for whom the matrices were ordered had supporting lab tests. Of the ordered matrices, 34.3% were not applied. And, the use of matrices resulted in...
A study on the usage of skin...
01/22/2024
Wound Care
News
01/22/2024
Spectra AI has begun enrollment in a pivotal study to validate DeepView AI for burn injuries and will be conducted in burn centers and emergency departments across the US, enrolling adults and pediatric patients. The data obtained will be...
Spectra AI has begun enrollment in a pivotal study to validate DeepView AI for burn injuries and will be conducted in burn centers and emergency departments across the US, enrolling adults and pediatric patients. The data obtained will be...
Spectra AI has begun enrollment...
01/22/2024
Wound Care
News
01/22/2024
VityleBio (Gainsville, FL)’s US Patent Application “Regenerative Tissue Extract From Non-Human Mammalian Placenta“ was published describing mammalian placental extract compositions having regenerative properties suitable for treatment of...
VityleBio (Gainsville, FL)’s US Patent Application “Regenerative Tissue Extract From Non-Human Mammalian Placenta“ was published describing mammalian placental extract compositions having regenerative properties suitable for treatment of...
VityleBio (Gainsville, FL)’s US...
01/22/2024
Wound Care
News
01/22/2024
A 2,160-pt study identified the frequency of cellulitis in patients with lymphedema of the arm and risk factors for cellulitis. The prevalence of cellulitis was 22%, and 1-year incidence was 11%. Risk factors included longer swelling duration...
A 2,160-pt study identified the frequency of cellulitis in patients with lymphedema of the arm and risk factors for cellulitis. The prevalence of cellulitis was 22%, and 1-year incidence was 11%. Risk factors included longer swelling duration...
A 2,160-pt study identified the...
01/22/2024
Wound Care
News
01/22/2024
For Q423, Mölnlycke reported revenue of ~$549.3MM (€505.0MM), +6.5% (+9.0% organic in CC) vs Q422. Currency impact -2.5%. Wound Care represented 59% of sales for the last 12 months, with Q423 organic growth in CC of +9% and growth across all...
For Q423, Mölnlycke reported revenue of ~$549.3MM (€505.0MM), +6.5% (+9.0% organic in CC) vs Q422. Currency impact -2.5%. Wound Care represented 59% of sales for the last 12 months, with Q423 organic growth in CC of +9% and growth across all...
For Q423, Mölnlycke reported...
01/22/2024
Wound Care
News
01/15/2024
Sanara signed an exclusive license agreement with Tufts University to develop and commercialize patented tech covering 18 unique collagen peptides. As a result, Sanara has formed a new subsidiary, Sanara Collagen Peptides, LLC (SCP), and...
Sanara signed an exclusive license agreement with Tufts University to develop and commercialize patented tech covering 18 unique collagen peptides. As a result, Sanara has formed a new subsidiary, Sanara Collagen Peptides, LLC (SCP), and...
Sanara signed an exclusive...
01/15/2024
Wound Care
News
01/15/2024
Avita announced an exclusive multi-year distribution agreement with Stedical Scientific to commercialize PermeaDerm Biosynthetic Wound Matrix in the US. For burn or wound procedures treated with Spray-On Skin from the RECELL System,...
Avita announced an exclusive multi-year distribution agreement with Stedical Scientific to commercialize PermeaDerm Biosynthetic Wound Matrix in the US. For burn or wound procedures treated with Spray-On Skin from the RECELL System,...
Avita announced an exclusive...
01/15/2024
Wound Care

Advertisement

Advertisement

Advertisement